Avoro Capital discloses 9.64% Arrowhead Pharmaceuticals (ARWR) stake including warrants
Arrowhead Pharmaceuticals (ARWR) disclosed that Avoro Capital Advisors LLC and controlling person Behzad Aghazadeh beneficially own 13,823,383 shares, including 2,467,828 shares issuable on warrant exercise. Using 140,857,021 shares outstanding as of May 1, 2026, the stake equals 9.64% assuming warrants are exercised.
How this was made
The 30-second read
Why it matters
The disclosure updates the shareholder register and may influence expectations around future governance or strategic positioning, but it does not provide new company fundamentals.
Market read
A near-10% beneficial ownership disclosure with warrant exposure can affect positioning and sentiment, but lacks operational or financial triggers.
What to watch
Traders should monitor whether warrants are exercised, whether the stake changes materially, and whether any separate 13D activist-style intent is later disclosed.
Background
The filing is a Schedule 13G/A under the Securities Exchange Act, reporting beneficial ownership for investment purposes.
Ticker impact
Avoro Capital Advisors disclosed a 9.64% beneficial stake in Arrowhead, including 2.47M shares issuable on warrant exercise.
Likely limited near-term impact; watch for follow-on filings or changes in stake size.
The article is a regulatory ownership update (Schedule 13G) with no new clinical, financial, or deal terms. However, a near-10% holder can affect sentiment and future governance expectations.
Market effects
Minor read-through for biotech ownership concentration and potential activist or strategic interest, without sector-wide fundamentals.
No clear regional spillover beyond US small/mid-cap biotech sentiment.
Primarily US-focused ownership transparency; no direct global catalyst described.
Counterpoint
A Schedule 13G/A can reflect passive investment intent, so the market may overreact to the headline ownership percentage.
Key entities
- issuerArrowhead Pharmaceuticals, Inc.
US biotech company whose beneficial ownership stake was disclosed, including warrant-issuable shares.
- reporting personAvoro Capital Advisors LLC
Investment adviser reporting beneficial ownership of Arrowhead shares and warrants.
- controlling personBehzad Aghazadeh
Controlling person of Avoro reporting sole voting and dispositive power over the disclosed stake.
